Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) agreed to acquire 68% stake in Osmopharm SA for SAR 16.1 million on November 14, 2023. The transaction s expected to be completed in the first half of 2024, contingent on regulatory approvals. Olha Demianiuk and Dr. Alexander Wyss of Baker & McKenzie acted as legal advisor to Saudi Pharmaceutical Industries and Medical Appliances Corporation.
Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.35 SAR | -0.53% | -1.06% | -1.19% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-1.19% | 1.19B | |
+26.15% | 681B | |
+21.85% | 556B | |
-5.11% | 361B | |
+17.41% | 325B | |
+5.01% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.08% | 157B |
- Stock Market
- Equities
- 2070 Stock
- News Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million.